MedTrace Logo

Biphasic Calcium Phosphate vs. Hydroxyapatite in Sinus Floor Elevation

NCT04331314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-04-02

No results posted yet for this study

Summary

Twenty patients scheduled for lateral-window sinus floor Elevation (SFE) are randomized into two groups: use of SYMBIOS® Biphasic Bone Graft Material (Group 1) or of Algipore® Bone Substitution Material (Group 2).

Biopsies are taken 3 months after SFE and during implant surgery after 6 months. One ground section per biopsy (n=40) is stained, scanned, and histomorphometrically analyzed for new bone, old bone, soft tissue, graft, bone infiltration of graft, bone-to-graft contact, and penetration depth.

Conditions

  • Bone Substitutes
  • Calcium Phosphates
  • Hydroxyapatite
  • Rhodophyta
  • Sinus Floor Augmentation

Interventions

DEVICE

Use of Symbios Bone Graft Material

Patients will receive Symbios Bone Graft Material according to randomization Group.

DEVICE

Algipore Bone Substitution Material

Patients will receive Algipore Bone Substitution Material according to randomization Group.

Sponsors & Collaborators

  • Dentsply Sirona Implants and Consumables

    collaborator INDUSTRY

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Walther Wegscheider, Prof. DDr. · Head of Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-23
Primary Completion
2018-03-20
Completion
2019-10-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04331314 on ClinicalTrials.gov